When red blood cells break down, they release heme, a component of hemoglobin that can contribute to inflammation and damage ...

Researchers discovered a possible way cancer cells hide from the immune system: they build a thick, sugar-rich coating around ...

Aug 26 (Reuters) - Bristol Myers Squibb has ended its partnership with cell therapy startup Cellares to expand the ...

Precancerous blood cells can actively reshape their surroundings, prematurely aging cells in the bone marrow to create ...

Mimrylo was cleared to treat polycythemia vera, a chronic blood cancer in which overproduction of red blood cells thickens a ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

During a live event, Casey L. O'Connell, MD, and participants considered how white blood cell count may factor into risk ...

Blood donors are needed.

Blood donors are needed every day to support patients undergoing medical treatments, including those living with sickle cell disease. During Sickle Cell Awareness Month in September, Vitalant is ...

Researchers at the University of California San Diego School of Medicine have been awarded a contract of up to $11.312 ...

Traceable, high-quality primary cell portfolio addresses long-standing bottlenecks in cardiovascular research HUSTON, ...

The clearance and broader-than-expected label for Mimrylo open up a yearly revenue opportunity for Takeda that some analysts ...